Agelity® and cognitive aging: what the research shows
Recent scientific coverage highlights Agelity®, Advenion Nutrition’s standardized D-Pinitol ingredient, as a novel nutritional approach relevant to cognitive aging and brain metabolic health. Drawing on peer-reviewed research, the article explores how Agelity® may support healthy brain insulin signaling and help maintain balanced cellular signaling involved in healthy brain function during aging.
The coverage positions Agelity® — a standardized, traceable source of D-Pinitol — as a science-driven ingredient with potential applications in cognitive health maintenance and healthy brain aging. By focusing on the specific Agelity® ingredient rather than generic D-Pinitol, the coverage reinforces the value of standardization and analytical control. Detailed mechanistic findings are available to qualified R&D and formulation partners on request.
This article summarizes preclinical and review research and is intended for scientific and product-development audiences. These statements have not been evaluated by the Food and Drug Administration. Agelity® is an ingredient and is not intended to diagnose, treat, cure, or prevent any disease, including Alzheimer’s disease.